Author(s): Parker C, Waters R, Leighton C, Hancock J, Sutton R, Moorman AV, Ancliff P, Morgan M, Masurekar A, Goulden N, Green N, Revesz T, Darbyshire P, Love S, Saha V
Keywords: DOSE ARA-C CHILDHOOD LEUKEMIA ACCELERATED APPROVAL PEDIATRIC-PATIENTS ONCOLOGY GROUP RISK IDARUBICIN EXPERIENCE THERAPY SENSITIVITY
|
Professor Anthony Moorman
|
|